| # | Drug | Count |
|---|---|---|
| 0 | OMALIZUMAB | 64 |
| 1 | METHOTREXATE SODIUM | 59 |
| 2 | LEFLUNOMIDE | 51 |
| 3 | METHOTREXATE | 48 |
| 4 | ADALIMUMAB | 45 |
| 5 | HYDROXYCHLOROQUINE | 44 |
| 6 | PREDNISONE | 30 |
| 7 | COLCHICINE | 28 |
| 8 | METFORMIN | 27 |
| 9 | NAPROXEN SODIUM | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMALIZUMAB-IGEC | 1 | 0.0112 |
| 1 | COSYNTROPIN | 1 | 0.0045 |
| 2 | DEXTRAN, HYPROMELLOSE | 1 | 0.0043 |
| 3 | ESMOLOL HYDROCHLORIDE | 1 | 0.0037 |
| 4 | FLUOROMETHOLONE ACETATE | 1 | 0.0037 |
| 5 | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | 11 | 0.0027 |
| 6 | INFLIXIMAB-DYYB | 8 | 0.0023 |
| 7 | GOLIMUMAB | 26 | 0.0021 |
| 8 | ULIPRISTAL ACETATE | 1 | 0.0020 |
| 9 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 2 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 78 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 69 |
| 2 | Anti-IgE [EPC] | 65 |
| 3 | Corticosteroid [EPC] | 64 |
| 4 | Antirheumatic Agent [EPC] | 51 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 48 |
| 6 | Proton Pump Inhibitor [EPC] | 41 |
| 7 | Alkaloid [EPC] | 28 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 26 |
| 9 | Estrogen [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Allylamine Antifungal [EPC] | 12 | 0.0017 |
| 2 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 3 | Lipopeptide Antibacterial [EPC] | 10 | 0.0011 |
| 4 | Alkaloid [EPC] | 28 | 0.0011 |
| 5 | Sulfone [EPC] | 10 | 0.0009 |
| 6 | Anti-IgE [EPC] | 65 | 0.0007 |
| 7 | Interleukin-17A Antagonist [EPC] | 24 | 0.0006 |
| 8 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 9 | Human Immunoglobulin G [EPC] | 11 | 0.0005 |